Genetic Causes and Modifiers of Autism Spectrum Disorder

Autism Spectrum Disorder (ASD) is one of the most prevalent neurodevelopmental disorders, affecting an estimated 1 in 59 children. ASD is highly genetically heterogeneous and may be caused by both inheritable and de novo gene variations. In the past decade, hundreds of genes have been identified tha...

Full description

Bibliographic Details
Main Authors: Lauren Rylaarsdam, Alicia Guemez-Gamboa
Format: Article
Language:English
Published: Frontiers Media S.A. 2019-08-01
Series:Frontiers in Cellular Neuroscience
Subjects:
CNV
Online Access:https://www.frontiersin.org/article/10.3389/fncel.2019.00385/full
id doaj-fd1f1a23350143fba5bb82162d26d81e
record_format Article
spelling doaj-fd1f1a23350143fba5bb82162d26d81e2020-11-25T01:57:51ZengFrontiers Media S.A.Frontiers in Cellular Neuroscience1662-51022019-08-011310.3389/fncel.2019.00385470832Genetic Causes and Modifiers of Autism Spectrum DisorderLauren RylaarsdamAlicia Guemez-GamboaAutism Spectrum Disorder (ASD) is one of the most prevalent neurodevelopmental disorders, affecting an estimated 1 in 59 children. ASD is highly genetically heterogeneous and may be caused by both inheritable and de novo gene variations. In the past decade, hundreds of genes have been identified that contribute to the serious deficits in communication, social cognition, and behavior that patients often experience. However, these only account for 10–20% of ASD cases, and patients with similar pathogenic variants may be diagnosed on very different levels of the spectrum. In this review, we will describe the genetic landscape of ASD and discuss how genetic modifiers such as copy number variation, single nucleotide polymorphisms, and epigenetic alterations likely play a key role in modulating the phenotypic spectrum of ASD patients. We also consider how genetic modifiers can alter convergent signaling pathways and lead to impaired neural circuitry formation. Lastly, we review sex-linked modifiers and clinical implications. Further understanding of these mechanisms is crucial for both comprehending ASD and for developing novel therapies.https://www.frontiersin.org/article/10.3389/fncel.2019.00385/fullautism spectrum disordergenetic modifiersCNVepigeneticsgene-environment interaction
collection DOAJ
language English
format Article
sources DOAJ
author Lauren Rylaarsdam
Alicia Guemez-Gamboa
spellingShingle Lauren Rylaarsdam
Alicia Guemez-Gamboa
Genetic Causes and Modifiers of Autism Spectrum Disorder
Frontiers in Cellular Neuroscience
autism spectrum disorder
genetic modifiers
CNV
epigenetics
gene-environment interaction
author_facet Lauren Rylaarsdam
Alicia Guemez-Gamboa
author_sort Lauren Rylaarsdam
title Genetic Causes and Modifiers of Autism Spectrum Disorder
title_short Genetic Causes and Modifiers of Autism Spectrum Disorder
title_full Genetic Causes and Modifiers of Autism Spectrum Disorder
title_fullStr Genetic Causes and Modifiers of Autism Spectrum Disorder
title_full_unstemmed Genetic Causes and Modifiers of Autism Spectrum Disorder
title_sort genetic causes and modifiers of autism spectrum disorder
publisher Frontiers Media S.A.
series Frontiers in Cellular Neuroscience
issn 1662-5102
publishDate 2019-08-01
description Autism Spectrum Disorder (ASD) is one of the most prevalent neurodevelopmental disorders, affecting an estimated 1 in 59 children. ASD is highly genetically heterogeneous and may be caused by both inheritable and de novo gene variations. In the past decade, hundreds of genes have been identified that contribute to the serious deficits in communication, social cognition, and behavior that patients often experience. However, these only account for 10–20% of ASD cases, and patients with similar pathogenic variants may be diagnosed on very different levels of the spectrum. In this review, we will describe the genetic landscape of ASD and discuss how genetic modifiers such as copy number variation, single nucleotide polymorphisms, and epigenetic alterations likely play a key role in modulating the phenotypic spectrum of ASD patients. We also consider how genetic modifiers can alter convergent signaling pathways and lead to impaired neural circuitry formation. Lastly, we review sex-linked modifiers and clinical implications. Further understanding of these mechanisms is crucial for both comprehending ASD and for developing novel therapies.
topic autism spectrum disorder
genetic modifiers
CNV
epigenetics
gene-environment interaction
url https://www.frontiersin.org/article/10.3389/fncel.2019.00385/full
work_keys_str_mv AT laurenrylaarsdam geneticcausesandmodifiersofautismspectrumdisorder
AT aliciaguemezgamboa geneticcausesandmodifiersofautismspectrumdisorder
_version_ 1724972055600824320